Bank of New York Mellon Corp bought a new stake in shares of Celanese Corporation (NYSE:CE - Free Report) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 679,580 shares of the basic materials company's stock, valued at approximately $31,261,000. Bank of New York Mellon Corp owned approximately 0.62% of Celanese as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the business. Geneos Wealth Management Inc. increased its position in shares of Celanese by 111.1% during the second quarter. Geneos Wealth Management Inc. now owns 513 shares of the basic materials company's stock valued at $28,000 after buying an additional 270 shares during the period. National Bank of Canada FI purchased a new stake in Celanese in the third quarter worth $34,000. Smartleaf Asset Management LLC raised its holdings in Celanese by 100.0% in the second quarter. Smartleaf Asset Management LLC now owns 662 shares of the basic materials company's stock worth $38,000 after purchasing an additional 331 shares in the last quarter. UMB Bank n.a. raised its holdings in Celanese by 175.7% in the fourth quarter. UMB Bank n.a. now owns 896 shares of the basic materials company's stock worth $38,000 after purchasing an additional 571 shares in the last quarter. Finally, Kestra Advisory Services LLC purchased a new position in Celanese during the fourth quarter valued at $41,000. Hedge funds and other institutional investors own 98.87% of the company's stock.
Insiders Place Their Bets
In other Celanese news, SVP Mark Christopher Murray purchased 2,153 shares of the firm's stock in a transaction on Tuesday, August 11th. The shares were acquired at an average cost of $45.52 per share, for a total transaction of $98,004.56. Following the completion of the transaction, the senior vice president owned 30,432 shares of the company's stock, valued at approximately $1,385,264.64. The trade was a 7.61% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.34% of the company's stock.
Analyst Ratings Changes
A number of analysts have recently commented on CE shares. JPMorgan Chase & Co. boosted their target price on shares of Celanese from $53.00 to $68.00 and gave the company an "overweight" rating in a report on Thursday, May 7th. Bank of America dropped their price objective on shares of Celanese from $72.00 to $63.00 and set a "buy" rating on the stock in a research note on Tuesday, June 30th. BMO Capital Markets decreased their target price on shares of Celanese from $57.00 to $54.00 and set a "market perform" rating for the company in a research note on Wednesday, August 5th. Wall Street Zen downgraded shares of Celanese from a "buy" rating to a "hold" rating in a research note on Saturday, June 20th. Finally, Weiss Ratings reissued a "sell (d-)" rating on shares of Celanese in a research report on Friday, August 21st. Nine analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company's stock. Based on data from MarketBeat, Celanese currently has a consensus rating of "Hold" and a consensus target price of $63.71.
Check Out Our Latest Research Report on CE
Celanese Price Performance
NYSE CE opened at $44.95 on Friday. The company has a debt-to-equity ratio of 2.33, a current ratio of 1.45 and a quick ratio of 0.87. Celanese Corporation has a 1-year low of $35.13 and a 1-year high of $70.70. The stock has a market capitalization of $4.93 billion, a price-to-earnings ratio of -4.20, a PEG ratio of 0.29 and a beta of 0.76. The business's fifty day moving average price is $46.00 and its 200-day moving average price is $53.58.
Celanese (NYSE:CE - Get Free Report) last posted its quarterly earnings data on Tuesday, August 4th. The basic materials company reported $2.45 EPS for the quarter, beating analysts' consensus estimates of $2.23 by $0.22. Celanese had a positive return on equity of 13.04% and a negative net margin of 12.04%.The company had revenue of $2.75 billion during the quarter, compared to analysts' expectations of $2.75 billion. During the same quarter in the prior year, the business earned $1.44 earnings per share. Celanese's revenue for the quarter was up 8.7% compared to the same quarter last year. Celanese has set its Q3 2026 guidance at 1.350-1.750 EPS. On average, equities analysts predict that Celanese Corporation will post 5.99 earnings per share for the current year.
Celanese Announces Dividend
The firm also recently announced a quarterly dividend, which was paid on Monday, August 10th. Shareholders of record on Tuesday, July 28th were issued a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, July 28th. Celanese's dividend payout ratio is currently -1.12%.
Celanese Company Profile
(
Free Report)
Celanese Corporation is a global chemical and specialty materials company that develops, manufactures and markets a broad portfolio of products serving diverse industries. The company operates through two primary business segments—Engineered Materials and Acetyl Chain—offering solutions that range from high-performance polymers and specialty additives to industrial chemicals and intermediates. Its engineered materials are used in applications such as automotive components, consumer electronics, medical devices and packaging, while its acetyl derivatives find uses in coatings, adhesives, solvents and personal care products.
In the Engineered Materials segment, Celanese produces a variety of high-performance thermoplastics, polyether-block-amide (PEBA) elastomers and functional additives designed to enhance product durability, thermal resistance and sustainability.
Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Celanese, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Celanese wasn't on the list.
While Celanese currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.